The Vevo 2100 Micro-ultrasound plus LAZR Photoacoustic Imaging Platform
The Vevo/LAZR ultrasound/photoacoustic imaging facility will allow researchers to visualize and quantify, non-invasively, tissue and molecular structures, the movement and behaviour of cells and the delivery patterns of administered imaging dyes and nanoparticles in mouse models and reconstructed tissues. This will enable the collection of anatomical, functional, physiological and molecular data simultaneously and in real-time, with resolution down to 40 μm.
This facility will allow development and optimisation of new techniques for gathering data about the body’s normal function not obtainable via other current technologies. This knowledge should have wide-reaching implications for understanding normal human physiology and future development of new molecular targeting agents for pathophysiological states such as wound healing, inflammation, cancer and obesity/diabetes, with potential progression to patenting and commercial development.
It is anticipated that the imaging instrument will be purchased and set up for operation in the first half of 2015. This will be the first of its kind in Australia.
Investigators
Pamela Russell | APCRC-Q, IHBI, QUT, TRI |
Glenda Gobe | University of Queensland |
John Hooper | Mater Research |
Adrian Herington | APCRC-Q, IHBI, QUT, TRI |
Christian Langton | IHBI, QUT |
Kristofer Thurecht |
Australian Institute for Bioengineering and Nanotechnology, University of Queensland |
Ian Brereton | Centre for Advanced Imaging, University of Queensland |
Ian Frazer | Translational Research Institute |
Andrew Fielding | University of Queensland |
Dietmar Hutmacher | APCRC-Q, IHBI, QUT, TRI |
Michelle Hill | Institute for Molecular Bioscience, University of Queensland |
Josephine Forbes | University of Queensland |
Allison Pettit | University of Queensland |
Kate Johnston | Translational Research Institute |
Duration
Funding
Australian Research Council Linkage, Infrastructure, Equipment and Facilities Grant | $370 674 |